title: [Not Available].
abstract: WHERE CAN WE GO?: Adjuvant radiotherapy (RT) has an important role in the management of infiltrating breast cancer, not only to improve local control but also overall survival. So, all attempt of de-escalation must be performed in the context of large prospective studies. However, RT could induce some complications and last 5 to 7 weeks. Three ways of RT de-escalation have been studied.
authors: Service de cancérologie-radiothérapie, Hôpital Saint-Louis, Paris. Electronic address: christophe.hennequin2@aphp.fr.
authors: Christophe
authors: C
authors: Hennequin
authors: Service de cancérologie-radiothérapie, Hôpital Saint-Louis, Paris.
authors: Sophie
authors: S
authors: Guillerm
authors: Service de cancérologie-radiothérapie, Hôpital Saint-Louis, Paris.
authors: Laurent
authors: L
authors: Quero
mesh_terms: D001918:Brachytherapy; D001943:Breast Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D018270:Carcinoma, Ductal, Breast / Q000473:pathology / Q000532:radiotherapy*; D005260:Female; D006801:Humans; D015182:Lymphatic Irradiation; D000069473:Radiation Dose Hypofractionation; D011878:Radiotherapy / Q000009:adverse effects; D018714:Radiotherapy, Adjuvant
keywords: Breast cancer; Cancer du sein; Intra-operative; Irradiation partielle; Irradiation per-opératoire; Partial breast irradiation; Radiotherapy; Radiothérapie; irradiation